Break out is coming Potential 20% profit on confirmed break out with low risk and ideal Risk/Reward ratio.
1st target 12.5$
2nd target as per upper yellow line
MNMD trade ideas
A 51% upside trade idea watchlist add before we moon!NASDAQ:MNMD
Inverse H&S
$10.44 BREAKOUT =🎯$12.25🎯$15.60
Called this one out a few months ago and how RFK Jr. would send the Psychedelic's Stock flying...He did just that after his inauguration. It could keep flying now with momentum!
Not financial advice
MNMD LONGBreakout, CHoCH, volume supporting the move, 20.82 target, march Opex expiration. nothing big, I like the setup. why are we running tho??
The confirmation of Robert F. Kennedy Jr. as the head of the U.S. Department of Health and Human Services could have a positive impact on biotech stocks, particularly in the psychedelic space. RFK Jr.'s support for mental health treatments using psychedelics like those being developed by Mind Medicine (MNMD) aligns with a potential shift in policy towards chronic disease prevention and alternative therapies. Analysts believe this could boost biotech companies focused on psychedelics, such as MNMD, which saw a slight uptick in stock following his confirmation.
Keep a close eye on $MNMDMind Medicine (MindMed) Inc. ( NASDAQ:MNMD ): Technical and Fundamental Analysis
As of February 3, 2025, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is trading at $7.26, an increase of $0.47 (approximately 6.92%) from the previous close.
Mind Medicine Inc (MNMD) is an equity in the U.S. market. The current price is $7.26, with a change of 0.47 (6.92%) from the previous close. The intraday high is $7.45, and the intraday low is $6.53. The latest trade time is Monday, February 3, 17:55:43 UTC.
Technical Analysis
Recent trading activity shows an intraday high of $7.45 and a low of $6.53, indicating increased volatility. Technical indicators, such as moving averages and oscillators, suggest mixed signals. However, there is a significant increase in trading volume, which often signals strong momentum. Additionally, breakout potential is huge, with the possibility of a major price surge if key resistance levels are broken. According to TradingView, there is a neutral to slightly positive trend, with some indicators pointing to a potential upward move. (tradingview.com)
Fundamental Analysis
Mind Medicine focuses on developing psychedelic-based medicines for mental health treatments. The company has recently reported strong news, including positive results from clinical trials, which has attracted investor interest. Financial reports indicate increased spending on research and development, signaling an active pipeline of projects. However, like many biotech companies in the development phase, Mind Medicine currently does not generate significant revenue and relies on investor funding.
Conclusion
With increasing volume, strong news, and massive breakout potential, the chance of a major price surge is high. Keep a close eye on this stock and put MNMD on your radar! 🚀
MNMD: The $36.55 Moonshot or Mirage? Boom or Bust Play!MNMD is displaying significant bullish momentum, recently establishing support at $4.50, where a key gap has formed. This level is now acting as a base for a potential continuation move, setting the stage for an explosive breakout.
The stock is currently approaching the $12.22 weekly resistance level, a critical psychological and technical barrier. A decisive breakout above this level would confirm the bullish trend and attract momentum traders, likely fueling a strong rally.
Why MNMD Could Push to $36.55:
🔹 Technical Momentum: Recent price action indicates strong accumulation, with increasing volume signaling growing investor interest. The stock has consistently made higher lows, reinforcing its bullish structure.
🔹 Gap Fill Potential: Historical price action suggests that once a stock begins filling a previous gap, there’s a high probability of it continuing toward the next resistance. If MNMD sustains above $12.22, the next major resistance zone is at $36.55, providing substantial upside.
🔹 Favorable Risk-to-Reward Setup: With a stop-loss at $2.45, this trade offers an exceptional risk-to-reward ratio, making it an attractive opportunity for traders willing to capitalize on momentum.
🔹 Psychological and Institutional Levels: Breakouts above key whole-number resistance levels often attract increased buying pressure from institutions and retail traders alike. A move past $12.22 could trigger stop orders and FOMO buying, accelerating the uptrend.
Key Levels to Watch:
✅ Support: $4.50 (gap level), $2.45 (stop-loss)
✅ Breakout Trigger: $12.22 (weekly resistance)
✅ Target: $36.55 (major resistance)
If MNMD maintains its momentum and breaks above $12.22 with volume, this could be the beginning of a major move toward $36.55, delivering high-upside potential with controlled risk.
NASDAQ:MNMD
MindmedBeautiful cup&handle pattern forming .
Targets remains around 18$ .
Before a decent correction .
Sell a little if necessary, but for me this is a long term hold ( mostly ) .
To the 40-50$ region at least .
MNMDMNMD broke out of my falling wedge .
First target would be around 18$ , with jfk
( if he keeps his promise )
Opening new ways for companies with psychedelic treatments to prosper .
Company Fundamentals also seem quite good to me .
Crash back to 10$ in financial crisis Q2-Q3.
And then there is barely any resistance until 37$ - also 2026 is when all the trials get the end results / approvals .
MNMD: An optimal buy Call option hereMNMD: An optimal buy Call option here
-Long ABCD pattern.
-Inversed HnS pattern forming.
-Fibo golden zone at 0.168./
-Key level support.
-Logic volume together with spread.
.
Wait n see.
$MNMD looking for a good swing trade. On a more zoomed out NASDAQ:MNMD looks like it’s in a falling wedge. A little double bottom could be forming here as well. Will be accumulating $1500 or so in shares for a short term swing. Risk for me is $6.75 with a goal of $8.50 and leave some running.
WSL
MNMD 600% in 2025With Trump and RFK challenging the stronghold of big pharma, the suppression of psychedelic medicines may soon be over. Analysts have set a price target of $26. Market conditions and fresh speculative details render these companies highly volatile and speculative, as many are in trial phases and are losing money rather than profiting... for now.
MNMD - long - multi catalyst play - risky before 03/07/2024Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
This is not a financial advice!
4 upcoming catalysts 03/07/2024 , 03/31/2024, 06/30/2024 and 12/31/2024
2024-03-01 MNMD Reiterates Buy 75.00 Maintains HC Wainwright & Co.
Keep in mind the first catalyst is very close and we had already a nice run up. You can enter after the data release.
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 9, 11, 13, 16, 20, 24 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 4.5
TPs approx. 33 longterm
Most info on the chart.
Trade carefully!
MNMD - A Good Play or a Bad Trip?First, full disclosure - I took a position in MNMD on Monday of last week after it popped over the $5.00 barrier; it was a Trade Ideas (TI) "Trade of the Week" play, and I took it after careful tech analysis and considering the successes of the TI recommendations of the past. The stock took a dump on Tuesday, but I stayed in it because I thought the turndown was due to the anxiety in the overall market.
So, looking at the chart, the price held the 8-day EMA very well. The momentum is favorable for an increase in price, but I think this stock is subject to market conditions.
Several analysts (I think it is 7) have covered this company, and the target price looks to be intriguing. From Zolmax News :
The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $23.50
I did tie up a good bit of capital in this trade, so I will be selling some soon, bit I will hold a good amount as a long-term swing trade or investment.
Mind Med - hopes for growth in Future - long term bullishPreviously dicussed on Nov 30th similarities between mj and mush stocks. Saw good price movement and a clean breakout pull back set up. So purchased at 2.99 and exited at 3.65. Subsiquently news came out which was good and New LSD testing will be good for the future of the stock. Long term play. Still bullish on the future
$MNMD Volume breakout with gap fill potential payoutMNMD nice clean volume breakout with room to run in my opinion with potential big pay out on the gap fill at $5.5 zone
Good risk / reward idea , and I like the chart
MNMD6M
RSI is at a top.
MFI is at 60, not yet exhausted.
I think the RSI could hold at the top for a time on this timeframe.
1Y
RSI is at a bottom.
MFI is around 60, with a downward sloping trend.
I think we could hold a low RSI for a time on this timeframe going towards lower lows.
5Y
RSI is trending up, while it is correcting a bit.
MFI looks like it is trending up, while correcting a bit.
Conclusion: There is a gap around $2 that I believe we are going to fill. Around that could be a good entry point.
For my educational purpose, not to be used as financial advice.
MNMD gap fill to ~$6potential gap fill play on MNMD. would like to see some consolidation before the breakout
MNMD Long based on Fundmntls, Lvls and MetaWorldCrypto indicatorHypothesis: pharmaceutical company price depressed due to conflict between management and investor, price artificially low due to FUD.
Confluence on W1 charts:
1. Price near ATL and 2020 support levels (year of IPO), see Early 2020 Support, and 2020 Support Levels.
2. Advanced RSI in oversold band with three Regular Divergence -Bullish signals
3. Setups & Trends also showing same three Regular Divergence - Bullish signals (same signals as above)
4. StRSI <10% with K crossed up D
Confluence on H1 chart
1. Price below Early 2020 and 2020 support levels and bouncing off Oct 2022 support.
2. Setup & Trend and Advanced RSI showing three Regular Divergence - Bull signals
Position: Entered at $2.82 with SL at $2.70, TP1 at $3.75
Risk Management: RR 7.75, Portfolio Risk % 0.43%, SL% Loss 4.26%, TP1% Gain 32.98%
MNMD crucial areaneed to break down trend from 1 week and catch support to move upward again pre split
MNMD Biotech Penny Stock SHORT SETUPNASDAQ:MNMD
Yj
This stock had a quick response to good earnings and
it is now at resistance with the RSI swing indicator
printing a Sell Signal.
The MACD, a lagging indicator, shows the signal
above the histogram without a K / D cross
not yet started.
I would like to take a short trade setting a stop loss
above the resistance zone and targeting 10%
to the POC line of the volume profile sitting above
the support zone.
Please comment and offer your opinion.
3
Infected MushroomSince selling into the listing day pump (sorry) I've been waiting patiently for $1 MMED.
Daily RSI is now 50+ and showing bullish divergence.
Now that MMED has a new CEO, I have more faith in MMED to deliver useful therapeutics. A more telling bottom signal is the change of CFO; let's hope Mr. "Greenway" lives up to his name :)
mindmed.co
How does minus 50 pct sound
This stock has no cash flow. Pure speculation.
Sell the news.
If you pay the FOMO price, you're going to get rekt.
I'll be loading up again in the $3 to $4 range.
Mind Medicine Canada Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
